149 related articles for article (PubMed ID: 8454628)
1. Recombinant soluble human interleukin-5 (hIL-5) receptor molecules. Cross-linking and stoichiometry of binding to IL-5.
Devos R; Guisez Y; Cornelis S; Verhee A; Van der Heyden J; Manneberg M; Lahm HW; Fiers W; Tavernier J; Plaetinck G
J Biol Chem; 1993 Mar; 268(9):6581-7. PubMed ID: 8454628
[TBL] [Abstract][Full Text] [Related]
2. Expression and in vitro properties of guinea pig IL-5: comparison to human and murine orthologs.
Scott CW; Budzilowicz C; Hubbs SJ; Stein M; Sobotka-Briner C; Wilkins DE
Mediators Inflamm; 2000; 9(3-4):181-7. PubMed ID: 11132776
[TBL] [Abstract][Full Text] [Related]
3. Detailed analysis of the IL-5-IL-5R alpha interaction: characterization of crucial residues on the ligand and the receptor.
Cornelis S; Plaetinck G; Devos R; Van der Heyden J; Tavernier J; Sanderson CJ; Guisez Y; Fiers W
EMBO J; 1995 Jul; 14(14):3395-402. PubMed ID: 7628440
[TBL] [Abstract][Full Text] [Related]
4. Purification of receptor complexes of interleukin-10 stoichiometry and the importance of deglycosylation in their crystallization.
Hoover DM; Schalk-Hihi C; Chou CC; Menon S; Wlodawer A; Zdanov A
Eur J Biochem; 1999 May; 262(1):134-41. PubMed ID: 10231374
[TBL] [Abstract][Full Text] [Related]
5. Molecular cloning of the guinea-pig IL-5 receptor alpha and beta subunits and reconstitution of a high affinity receptor.
Scott CW; Logsdon NJ; Wilkins DE; Norris TE; Sobotka-Briner C; Hubbs S; Graham A
Cytokine; 2000 Jul; 12(7):858-66. PubMed ID: 10880229
[TBL] [Abstract][Full Text] [Related]
6. Reconstitution of the functional receptors for murine and human interleukin 5.
Takaki S; Murata Y; Kitamura T; Miyajima A; Tominaga A; Takatsu K
J Exp Med; 1993 Jun; 177(6):1523-9. PubMed ID: 8496674
[TBL] [Abstract][Full Text] [Related]
7. Characterization of a receptor for interleukin-5 on human eosinophils and the myeloid leukemia line HL-60.
Ingley E; Young IG
Blood; 1991 Jul; 78(2):339-44. PubMed ID: 2070072
[TBL] [Abstract][Full Text] [Related]
8. Biochemical and functional characterization of soluble form of IL-5 receptor alpha (sIL-5R alpha). Development of ELISA system for detection of sIL-5R alpha.
Kikuchi Y; Migita M; Takaki S; Tominaga A; Takatsu K
J Immunol Methods; 1994 Jan; 167(1-2):289-98. PubMed ID: 8308284
[TBL] [Abstract][Full Text] [Related]
9. Characterization of recombinant extracellular domain of human interleukin-10 receptor.
Tan JC; Braun S; Rong H; DiGiacomo R; Dolphin E; Baldwin S; Narula SK; Zavodny PJ; Chou CC
J Biol Chem; 1995 May; 270(21):12906-11. PubMed ID: 7759550
[TBL] [Abstract][Full Text] [Related]
10. Murine interleukin 5 receptor isolated by immunoaffinity chromatography: comparison of determined N-terminal sequence and deduced primary sequence from cDNA and implication of a role of the intracytoplasmic domain.
Yamaguchi N; Hitoshi Y; Takaki S; Murata Y; Migita M; Kamiya T; Minowada J; Tominaga A; Takatsu K
Int Immunol; 1991 Sep; 3(9):889-98. PubMed ID: 1931815
[TBL] [Abstract][Full Text] [Related]
11. Recombinant 55-kDa tumor necrosis factor (TNF) receptor. Stoichiometry of binding to TNF alpha and TNF beta and inhibition of TNF activity.
Loetscher H; Gentz R; Zulauf M; Lustig A; Tabuchi H; Schlaeger EJ; Brockhaus M; Gallati H; Manneberg M; Lesslauer W
J Biol Chem; 1991 Sep; 266(27):18324-9. PubMed ID: 1655744
[TBL] [Abstract][Full Text] [Related]
12. [Genetic engineering of cytokine system on the tuberculosis research].
Takatsu K
Kekkaku; 1991 Sep; 66(9):629-34. PubMed ID: 1942734
[TBL] [Abstract][Full Text] [Related]
13. Mutagenesis in the C-terminal region of human interleukin 5 reveals a central patch for receptor alpha chain recognition.
Morton T; Li J; Cook R; Chaiken I
Proc Natl Acad Sci U S A; 1995 Nov; 92(24):10879-83. PubMed ID: 7479902
[TBL] [Abstract][Full Text] [Related]
14. A scintillation proximity assay for human interleukin-5 (hIL-5) high-affinity binding in insect cells coexpressing hIL-5 receptor alpha and beta subunits.
Zhang J; Wu P; Kuvelkar R; Schwartz JL; Egan RW; Billah MM; Wang P
Anal Biochem; 1999 Mar; 268(1):134-42. PubMed ID: 10036172
[TBL] [Abstract][Full Text] [Related]
15. Expression, purification and crystallization of fully active, glycosylated human interleukin-5.
Guisez Y; Oefner C; Winkler FK; Schlaeger EJ; Zulauf M; Van der Heyden J; Plaetinck G; Cornelis S; Tavernier J; Fiers W
FEBS Lett; 1993 Sep; 331(1-2):49-52. PubMed ID: 8405410
[TBL] [Abstract][Full Text] [Related]
16. Engineering human interleukin-6 to obtain variants with strongly enhanced bioactivity.
Toniatti C; Cabibbo A; Sporena E; Salvati AL; Cerretani M; Serafini S; Lahm A; Cortese R; Ciliberto G
EMBO J; 1996 Jun; 15(11):2726-37. PubMed ID: 8654370
[TBL] [Abstract][Full Text] [Related]
17. Rapid methods for purification of human recombinant interleukin-5 (IL-5) using the anti-murine IL-5 antibody-coupled immunoaffinity column.
Mita S; Hosoya Y; Kubota I; Nishihara T; Honjo T; Takahashi T; Takatsu K
J Immunol Methods; 1989 Dec; 125(1-2):233-41. PubMed ID: 2607155
[TBL] [Abstract][Full Text] [Related]
18. Characterization of the murine IL-5 receptor complex with the use of a panel of monoclonal antibodies. Relationship to the murine IL-3 receptor.
Van der Heyden J; Devos R; Plaetinck G; Fache I; Fiers W; Tavernier J
J Immunol; 1991 Nov; 147(10):3413-8. PubMed ID: 1940345
[TBL] [Abstract][Full Text] [Related]
19. Activation of early response genes and cell proliferation by human interleukin-3, granulocyte-macrophage colony-stimulating factor, and interleukin-5 receptors: comparison with human interleukin-4 receptor signaling.
Chen JX; Watanabe S; Muto A; Miyajima A; Yokota T; Arai K
J Allergy Clin Immunol; 1994 Sep; 94(3 Pt 2):605-11. PubMed ID: 8083468
[TBL] [Abstract][Full Text] [Related]
20. Interleukin-6 (IL-6) antagonism by soluble IL-6 receptor alpha mutated in the predicted gp130-binding interface.
Salvati AL; Lahm A; Paonessa G; Ciliberto G; Toniatti C
J Biol Chem; 1995 May; 270(20):12242-9. PubMed ID: 7744875
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
